GABRIELLE HOCKER: Open Payments
NPI 1952141087 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,524 in 129 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $508 · 2025 $2,524
Food & beverage: $2,439Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $692 |
| Janssen Biotech, Inc. | 21 | $508 |
| Ardelyx, Inc. | 14 | $398 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $301 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $292 |
| Madrigal Pharmaceuticals | 3 | $109 |
| Ipsen Biopharmaceuticals, Inc | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| PFIZER INC. | 2 | $28 |
| Celltrion USA Inc. | 1 | $25 |
Products named: TREMFYA, RINVOQ, IBSRELA, XIFAXAN, ENTYVIO, CREON, REZDIFFRA, DUPIXENT.
Industry payments across PA — which companies pay providers there.
